(688166)"BrightGene Bio-Medical Technology Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 688166 · · 18 pages · Chinese
Summary by 6ix AI
The report highlights key financial metrics, including revenue and net profit figures, along with insights into research and development activities. It also discusses the company's ongoing clinical trials and product development initiatives, particularly in the area of innovative drugs. The report assures stakeholders of the accuracy and completeness of the information provided, with management taking legal responsibility for its contents.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
BrightGene Bio-Medical Technology Co. Ltd. on 6ix
Earlier from BrightGene Bio-Medical Technology
- (688166)"BrightGene Bio-Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Approval Notice for BGM0504 Tablets
- Announcement on Resolutions of the 25th Meeting of the 4th Board of Directors
- Announcement on Results of Shareholding Reduction by Shareholder
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- Semi-annual Report for 2026
Later from BrightGene Bio-Medical Technology
- (688166)"BrightGene Bio-Medical Technology Co., Ltd."Announcement on Amendments to the Articles of Association and Certain Internal Management Policies
- (688166)"BrightGene Bio-Medical Technology Co., Ltd."Announcement on Purchase of Liability Insurance for the Company and Its Directors and Senior Executives
- (688166)"BrightGene Bio-Medical Technology Co., Ltd."Announcement on Resignation of Independent Director and Non-independent Director and Adjustment of Members of Special Committees of the Board of Directors
- (688166)"BrightGene Bio-Medical Technology Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026
Follow BrightGene Bio-Medical Technology into a list and get an email when it puts out news.
Follow BrightGene Bio-Medical Technology